Cochlear Nucleus Profile Pluse Series

Press Releases

FDA approves new cochlear implant with easier access to MRI and expanded connectivity ready for Google’s direct streaming to Android smartphones

CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration’s (FDA) approval of the new Cochlear™ Nucleus®Profile™ Plus Series Cochlear Implant and the Nucleus 7 Sound Processor’s new built-in connectivity featuring direct streaming with compatible Android™ smartphones. FDA approves the new Cochlear Nucleus Profile Plus Series Cochlear Implant. With…